Summary
Our aim was to analyze the incidence of mutations in BRCA1 and BRCA2 genes in 54 families with breast/ovarian cancer. Families were selected from three Institutions following the standard criteria for hereditary breast/ovarian cancer. PCR amplification of all exons was performed, followed by SSCP, heteroduplex, PTT and sequencing analysis. We identified eight truncation mutations, three in the BRCA1 gene and five in the BRCA2 gene. Three of these mutations have not been reported previously by other groups: 308insA in one family, 3936 C>T in two families, for BRCA1, and 4970insTG in one family for BRCA2. In addition two families having Ashkenazi Jewish ancestors present the well known mutations 185delAG and 6174delT. Interestingly, 5 out of 11 families have mutations recurrent in Spanish families. Among the 54 families selected, seven have breast and ovary cancer cases, and only two presented a mutation in BRCA1 or BRCA2 genes. Other cancers as prostate and stomach are frequent among relatives carrying the mutation. Five cases of very early onset (<31 years old) breast cancer were detected. The frequencies of BRCA1 (0.074) and BRCA2 (0.13) mutations in our families is low but similar to the incidence found in other populations, like in Spain. Since is widely known that risk factors that modulate the development of breast cancer such as lifestyle risk factors, geographic location, country of origin and socioeconomic status, besides a familial history of breast cancer our findings suggest that the history of colonization and immigrations is very relevant when studying hereditary factors associated to breast cancer.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Sholnick MH, A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1Science 266: 66–71 1994
Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Keisell D, Ford D, Tonin P, Biship DT, Spurr NK, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkadottir RB, Easton DF, Bentley DR, Futreal PA, Ashworth A, Stratton MR, Identification of the breast cancer susceptibility gene BRCA2Nature 378: 789–792, 1995
Szabo CI, King M-C, Population genetics of BRCA1 and BRCA2Am J Hum Genet 60: 1013–1020, 1997
Liede A, Narod SA, Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2Hum Mutat 20: 413–424, 2002
Ruiz-Flores P, Sinilnikova OM, Badzioch M, Calderón-Garcidueñas AL, Chopin S, Fabrice JF, González-Guerrero JF, Szabo C, Lenoir G, Goldgar D, Barrera-Saldaña H, BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in MexicoHum Mutat 20: 474–475, 2002
Lahiri DK, Nurnberger J, A rapid non-enzymatic method for the preparation of the HMW DNA from blood for RFLP studiesNucl Ac Res 19: 5444, 1991
Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE, King M-C, Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten familiesNat Genet 8: 399–404, 1994
Johannsson O, Ostermeyer EA, Hakansson S, Friedman LS, Johansson U, Sellberg G, Bronndum-Nielsen K, Sele V, Olsson H, King M-C, Borg A, Founding BRCA1 mutations in hereditary breast and ovarian cancer in Southern SwedenAm J Hum Genet 58: 441–450, 1996
Gallardo M, Faúndez P, Cruz A, Rodriguez M, Alvarez M, Carvallo P, Screening for a BRCA1 mutation in a Chilean family with breast cancerRev Med Chile 132:203–210, 2004
Cifuentes L, Valenzuela C, Cruz-Coke R, Armanet L, Lyng C, Harb Z, Genetic characterization of the hospital population of Santiago, Chile Rev Med Chile 116: 28–33, 1988
Llort G, Munoz CY, Tuser MP, Guillermo IB, Lluch JR, Bale AE, Franco MA, Low frequency of recurrent BRCA1 and BRCA2 mutations in SpainHum Mutat 19:307- 313, 2002
Diez O, del Rio E, Domenech M, Sanz J, Cortes J, Brunet J, Alonso Mdel C, Baiget M, The identification of a new mutation in the BRCA2 gene by protein truncation analysis in a Spanish family with hereditary breast cancerMed Clin (Barc) 112:179–181, 1999
Diez O, Cortes J, Domenech M, Pericay C, Brunet J, Alonso C, Baiget M, BRCA2 germ-line mutations in Spanish male breast cancer patientsAnn Oncol 11:81–84, 2000
Moraga M, Rocco P, Miquel JF, Nervi F, Llop E, Rothhammer F, Carvallo P, Mitochondrial DNA polymorphisms in southern Chilean aboriginal populationsAm J Phys Anthropol 113: 19–29, 2000
Rocco P, Morales C, Moraga M, Miquel JF, Nervi F, Llop E, Carvallo P, Rothhammer F, Genetic composition of the Chilean population. Analysis of mitochondrial DNA polymorphismRev Med Chile 130:125–131, 2002
Risch H, McLaughlin J, Cole D, Rosen B, Bradley L, Kwan E, Jack E, Vesprini D, Kuperstein G, Abrahamson J, Fan I, Wong B, Narod S, Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancerAm J Hum Genet 68:700–710, 2001
Hohenstein P, Fodde R, Of mice and (wo)men: genotype–phenotype correlations in BRCA1 Hum Mol Genet 12 Spec No2:R271–R277, 2003
Campos B, Díez O, Alvarez C, Palma L, Doménech M, Balmaña J, Sanz J, Ramirez A, Alonso C, Carvallo P, Baiget M, Haplotype of the BRCA2 6857delAA mutation in 4 families with breast/ovarian cancer Med Clin (Barc) 123:543–545, 2004
Thompson D, Easton D, Cancer incidence in BRCA1 mutation carriers J Natl Cancer Inst 94: 1358–1365, 2002
The Breast Cancer Linkage Consortium, Cancer risks in BRCA2 mutation carriersJ Natl Cancer Inst 91: 1310–1316, 1999
Jakubowska A, Nej K, Huzarski T, Scott RJ, Lubinski J, BRCA2 gene mutations in families with aggregations of breast and Stomach cancersBr J Cancer 87:888–889, 2002
Diez O, Cortes J, Domenech M, Brunet J, Del Río E, Pericay C, Sanz J, Alonso C, Baiget M, BRCA1 mutation analysis in 83 Spanish in breast/ovarian cancer familiesInt J Cancer 83: 465–469, 1999
Blesa JR, Garcia JA, Ochoa E, Frequency of germline BRCA1 mutations among Spanish families, from a Mediterranean areaHum Mutat 15: 381–382, 2000
Osorio A, Barroso A, Martinez B, Cebrian A, San Roman JM, Lobo F, Robledo M, Benitez J, Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families Br J Cancer 82: 1266–1270, 2000
Díez O, Osorio A, Durán M, Martinez-Ferrandis JI, de la Hoya M, Salazar R, Vega A, Campos B, Rodríguez-López R, Velasco E, Chaves J, Díaz-Rubio E, Cruz JJ, Torres M, Esteban E, Cervantes A, Alonso C, San Román JM, González-Sarmiento R, Miner C, Carracedo A, Armengod ME, Caldés T, Benítez J, Baiger M, Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patiens: a high proportion of mutations unique to Spain and evidence of founder effectsHum Mutat 22:301–312, 2003
Joslyn SA, Foote ML, Nasseri K, Coughlin SS, Howe HL, Racial and ethnic disparities in breast cancer rates by age: NAACCR Breast Cancer ProjectBreast Cancer Res Treat 92:97–105, 2005
Acknowledgments
We are grateful of all family members who contributed to this study. We also thank Nancy Lamig and Pamela Alarcón for their valuable assistance with patients. Grant Sponsors: Fondecyt 1011076 and NIH-FIRCA grant R03 TW00847.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gallardo, M., Silva, A., Rubio, L. et al. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype–phenotype correlations. Breast Cancer Res Treat 95, 81–87 (2006). https://doi.org/10.1007/s10549-005-9047-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-005-9047-1